Triple-negative breast cancer (TNBC) represents 10–20% of breast cancer cases, and lack expression of estrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (HER2) [2]. Here, ESR1 is linked to breast carcinoma.